Down-regulation of TYRO3 via RNAi in breast, colon, head and neck and pancreatic cancers has been reported to regulate the cellular signaling pathway by reducing the phosphorylation of STAT3, AKT, and ERK. This evidence concerns the gene AKT1 and familial pancreatic carcinoma.